Epilepsy is a neurological disorder characterized by recurrent seizures. Over the past decade, significant advancements have been made in the management of epilepsy, leading to improved patient outcomes. This article provides a comprehensive update on these developments.
Advancements in neuroimaging and electroencephalography (EEG) have enhanced our ability to diagnose epilepsy accurately. High-resolution MRI can identify structural abnormalities in the brain, and video-EEG monitoring can capture seizure activity, facilitating precise diagnosis and treatment.
Several new AEDs have been introduced, offering better seizure control and fewer side effects. Drugs like lacosamide, perampanel, and brivaracetam have shown promise in controlling seizures in patients who are refractory to traditional AEDs.
Surgical treatment for epilepsy has also seen significant advancements. Minimally invasive techniques, such as laser ablation therapy, can target and eliminate seizure foci without causing significant damage to surrounding brain tissue. Responsive neurostimulation, which delivers electrical pulses to inhibit seizures, is another promising approach.
Genetic testing has become increasingly important in epilepsy management. Identification of specific genetic mutations can guide treatment choices and provide prognostic information. This personalized approach to care is transforming epilepsy management.
Digital health technologies, including seizure detection and prediction devices, are playing an increasingly important role in epilepsy management. These tools can alert patients and caregivers to impending seizures, allowing for timely intervention.
In conclusion, advancements in epilepsy management are leading to improved patient outcomes. As healthcare professionals, we must stay abreast of these developments to provide the best possible care to our patients. The future of epilepsy management is promising, with ongoing research likely to yield even more effective treatments.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation